Alpha 2.0
Login Register
» Articles » PMID: 1802583

Regional Citrate Anticoagulation for Continuous Arteriovenous Hemodialysis. An Update After 12 Months

Overview
Journal Contrib Nephrol
Specialty Nephrology
Date 1991 Jan 1
PMID 1802583
Citations 9
Authors
R L Mehta
B R McDonald
D M Ward
Affiliations
Soon will be listed here.
Citing Articles

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation.

Santos T, Dos Santos Ferreira C, Mangueira C, Ammirati A, Scherer P, Petrucelli Doher M Sci Rep. 2023; 13(1):20176.

PMID: 37978209 PMC: 10656486. DOI: 10.1038/s41598-023-47644-1.

Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.

Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S Crit Care. 2019; 23(1):22.

PMID: 30678706 PMC: 6345001. DOI: 10.1186/s13054-019-2317-9.

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.

Raymakers-Janssen P, Lilien M, van Kessel I, Veldhoen E, Wosten-van Asperen R, van Gestel J Pediatr Nephrol. 2017; 32(10):1971-1978.

PMID: 28578542 PMC: 5579151. DOI: 10.1007/s00467-017-3694-4.

Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy.

Bouchard J, Madore F NDT Plus. 2015; 2(1):11-9.

PMID: 25949276 PMC: 4421492. DOI: 10.1093/ndtplus/sfn184.

Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.

Schilder L, Nurmohamed S, Bosch F, Purmer I, den Boer S, Kleppe C Crit Care. 2014; 18(4):472.

PMID: 25128022 PMC: 4161888. DOI: 10.1186/s13054-014-0472-6.